• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® D-DIMER EXCLUSION II ¿

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® D-DIMER EXCLUSION II ¿ Back to Search Results
Catalog Number 30455
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
Issue description: on (b)(6), 2023, a customer in serbia notified biomérieux of a potential false negative result with vidas d-dimer exclusion ii 60t (ref.(b)(4), batch 1009826570, expiry date 17-dec-2023) on patient samples.The affected patient had chronic obstructive pulmonary disease and he was on regular prescription of amlodipine and spiriva respimat.He was admitted in hospital on (b)(6), and after two (2) days he tested covid-19 positive.At the hospital admission and during his whole stay, the customer obtained d-dimer results 45 ng/ml for six (6) samples from the same patient with vidas d-dimer exclusion ii 60t (ref.(b)(4), batch 1009826570).During his stay the following therapies were prescribed: alvolamid (levofloxacin), ceftriaxon, captopril (zorkaptil), some probiotic and gastroprotective controloc, azosad.As the results were unusually and unexpectedly low result considering his diagnosis, the customer compared these results to another method (stago); he obtained 530 ng/ml.There is no indication or report from the laboratory that the issue led to any adverse event related to patient's state of health.A biomérieux internal investigation will be initiated.Note: reference (b)(4), is not registered in the united states.The u.S.Similar device is product reference (b)(4).
 
Manufacturer Narrative
An internal investigation was performed following a notification from a customer from serbia that they obtained false negative results when testing patient samples with vidas®d-dimer exclusion ii¿ - ref (b)(4), lot 1009826570.Device history record the review did not highlight any issue during manufacturing vidas®d-dimer exclusion ii¿ - ref (b)(4), lot 1009826570.Complaint analysis: at the date of investigation, no others complaints were recorded for false negative results on vidas® d-dimer exclusion ii¿ - ref (b)(4), lot 1009826570.Tests/analysis performed, customer¿s material, there was no patient sample return at the time of the complaint.The investigation has been performed with internal samples.Control charts analysis: the complaints laboratory analyzed the results of 4 internal samples targeted at 278 ng/ml ,585 ng/ml 741 ng/ml and 1341 ng/ml on 7 different batches of vidas®d-dimer exclusion ii¿ - ref (b)(4) including customer¿s lot 1009826570.The analysis of the control charts showed that all results were within specifications.Customer¿s lot is in the trend of the other lots.Tests performed by complaint laboratory - test on internal samples: the complaints laboratory tested 4 internal samples with concentrations targeted 278 ng/ml ,585 ng/ml 741 ng/ml and 1341 ng/ml with the retain kit vidas®d-dimer exclusion ii¿ - ref (b)(4), lot 1009826570.All samples results are within their expected specifications.There is no evolution since the batch release.Conclusion: according to all information above, no anomaly was highlighted with the control chart analysis, the analysis of quality data and the tests performed on retained kits vidas® d-dimer exclusion ii¿ - ref (b)(4), lot 1009826570 using internal samples.Customer¿s issue, were not reproduced by complaints laboratory during the investigation conducted on internal samples materials.Without customer¿s return sample and kit, the investigation cannot be pursued.There is no reconsideration of the performance of vidas® d-dimer exclusion ii¿ - ref (b)(4), lot 1009826570.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® D-DIMER EXCLUSION II ¿
Type of Device
VIDAS® D-DIMER EXCLUSION II ¿
Manufacturer (Section D)
BIOMERIEUX SA
376 chemin de l'orme
marcy l'étoile 69280
FR  69280
Manufacturer (Section G)
BIOMERIEUX SA
376 chemin de l'orme
marcy l'etoile 69280
FR   69280
Manufacturer Contact
ines el oueryemmi
5 rue des acqueducs
craponne 69290
FR   69290
MDR Report Key17325870
MDR Text Key319293419
Report Number8020790-2023-00045
Device Sequence Number1
Product Code DAP
Combination Product (y/n)N
PMA/PMN Number
K141133
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/17/2023
Device Catalogue Number30455
Device Lot Number1009826570
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/22/2023
Initial Date FDA Received07/14/2023
Supplement Dates Manufacturer Received08/17/2023
Supplement Dates FDA Received08/29/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
-
-